Phase I trial beginning in May for Pharmexa's Her-2 Protein AutoVac
-- ------------------------------------ This message was edited by Admin - 5/9/2003 |
Corixa Corporation in collaboration with GlaxoSmithKline Biologicals announces the initiation of a Phase I Trial of HER-2/Neu Vaccine designed to treat patients with high-risk breast cancer
|
All times are GMT -7. The time now is 06:06 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021